| Business Name: |
Luvera Vincent J DO |
| Contact Person: |
Vincent Luvera, |
| Address: |
323 Kings Road # 1, Schenectady, New York 12304 |
| Phone Number: |
(518) 393-8800 |
| Annual Revenue (USD): |
$500.000 to $999.999 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Doctors |
| SIC Code: |
8011 |
| NAICS Code: |
6211110 |
| Share This Business: |
|
| Related Businesses: |
Reilly Michael J MD - Schenectady, NY 12304
Us Oncology Inc - Schenectady, NY 12304
Mittal Peeyush MD - Schenectady, NY 12304
Barrowman Roger A MD - Schenectady, NY 12304
Fraterrigo Lynn E MD - Schenectady, NY 12304
Crafts Robert MD - Schenectady, NY 12304
Mc Grinder Gerard J MD - Schenectady, NY 12304
Lee Ernest MD - Schenectady, NY 12304
Schingo Jr Victor A MD - Schenectady, NY 12304
Wade Nancy A MD - Schenectady, NY 12304
Boler Lynn MD - Schenectady, NY 12304
Madden Jeena MD - Schenectady, NY 12304
Kaplan Irina Inna MD - Schenectady, NY 12304
Etienne Mineke E MD - Schenectady, NY 12304
Anumula Praveen MD - Schenectady, NY 12304
Chapados Gilles MD - Schenectady, NY 12304
Lee Arthur MD - Schenectady, NY 12304
Michael G Katlan - Schenectady, NY 12304
Fraterrigo Philip A MD - Schenectady, NY 12304
Rice Donald MD - Schenectady, NY 12304
|
The company Luvera Vincent J DO provides B2C services in the form of Doctors from its single location in New York.
1 to 4 employees work for Luvera Vincent J DO, and the business now earns $500.000 to $999.999 per annum.
Luvera Vincent J DO was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Luvera Vincent J DO, please call Vincent Luvera, with the phone number (518) 393-8800 or visit its single location at 323 Kings Road # 1 in Schenectady, New York 12304.
The location of the single location can also be found using the coordinates 42.775249,-73.912237.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.